Suchergebnisse - "Capparelli, Edmund V"

PubPharm (18)

1

Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age

enthalten in: The Pediatric infectious disease journal | 2024

von Bekker, A. | Yang, J. | Wang, J. | +11

2

Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study) : an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

enthalten in: The lancet. HIV | 2024

von Bekker, A. | Salvadori, N. | Rabie, H. | +10

ErratumIn: Lancet HIV. 2024 Apr 5;:. - PMID 38588690

3

Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients

enthalten in: Pharmacotherapy | 2023

von Salerno, S. | Capparelli, E. | McIlleron, H. | +5

4

Brief Report : Long-Term Clinical, Immunologic, and Virologic Outcomes Among Early-Treated Children With HIV in Botswana: A Nonrandomized Controlled Clinical Trial

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Ajibola, G. | Maswabi, K. | Hughes, M. | +14

5

Lopinavir and tenofovir interaction observed in non-pregnant adults altered during pregnancy

enthalten in: Journal of clinical pharmacy and therapeutics | 2021

von Mulligan, N. | Salama, E. | Momper, J. | +6

6

S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults

enthalten in: European journal of clinical pharmacology | 2021

von Tran, L. | Nikanjam, M. | Capparelli, E. | +5

7

Population Pharmacokinetics of Lopinavir/Ritonavir : Changes Across Formulations and Human Development From Infancy Through Adulthood

enthalten in: Journal of clinical pharmacology | 2018

von Yang, J. | Nikanjam, M. | Best, B. | +6

8

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

enthalten in: The Pediatric infectious disease journal | 2018

von Pinto, J. | Capparelli, E. | Warshaw, M. | +8

9

Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinations

enthalten in: Antiviral therapy | 2015

von Bouazza, N. | Foissac, F. | Fauchet, F. | +6

10

Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy

enthalten in: The Journal of antimicrobial chemotherapy | 2015

von Cressey, T. | Urien, S. | Capparelli, E. | +10